||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 507 active entries
Phone: +49- 6221-82780
Fax: +49- 6221-827824
Since 1983, PROGEN is an established manufacturer and supplier of premium antibodies, in vitro diagnostics, and reagents for the global life science research community. The portfolio serves customers in research institutes, universities, pharmaceutical & biotech companies or clinical laboratories. The DIN ISO 13485 company offers, antibodies for specialized research areas including lipid metabolism, cytokeratin, and cell adhesion as well as phage display technology, density gradient media, and AAV antibodies and test kits for gene therapy research. PROGEN’s antibodies are among the most published in biomedical & cell biology literature. With its 800+ antibody portfolio, PROGEN intends to become a driver of innovative antibody technologies for protein detection, quantification, and purification.
Further, the company has built an exclusive pipeline of ELISA kits for the assessment of adeno-associated viruses (AAV) titers for safe & effective gene therapy. Some of which have already earned reference standard status in centers around the world.
Since 2012, PROGEN has been a 100% subsidiary of the R-Biopharm AG in Darmstadt/Germany. This corporate affiliation offers new possibilities for the growth of PROGEN´s product & service portfolio.
Last update of this entry: September 23, 2019